Phibro Animal Health Corporation Reports Second Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Phibro Animal Health Corp. (PAHC) PT Raised to $34 at Piper Jaffray
February 8, 2017 9:17 AM ESTPiper Jaffray raised its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $34.00 (from $32.00) while maintaining a Overweight rating. Phibro reported in-line revenues and upside to earnings for 2Q17, where revenues of $192M were only slightly below the Street's estimates of $193M, while... More
Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
February 6, 2017 4:18 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $191.6 million versus the consensus estimate of $192.92 million.
FINANCIAL GUIDANCE
We have reaffirmed our financial guidance for the fiscal year 2017 as initially... More
